JAK-IN-1
JAK-IN-1 is a JAK1/2/3 inhibitor with IC50s of 0.26, 0.8 and 3.2 nM, respectively. JAK-IN-1 shows improved selectivity for JAK3 over JAK1.
Product Specifications
CAS Number
1334673-53-8
UNSPSC
12352005
Target
JAK
Type
Reference compound
Related Pathways
Epigenetics; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/JAK-IN-1.html
Concentration
10mM
Purity
98.39
Solubility
DMSO : 66.67 mg/mL (ultrasonic)
Smiles
O=C(C1=CNC2=NC=C(C3CC3)N=C21)N[C@@H](C(N4CC(C#N)C4)=O)C(C)(C)C
Molecular Formula
C20H24N6O2
Molecular Weight
380.44
References & Citations
[1]Soth M, et al. 3-Amido pyrrolopyrazine JAK kinase inhibitors: development of a JAK3 vs JAK1 selective inhibitor and evaluation in cellular and in vivo models. J Med Chem. 2013 Jan 10;56 (1) :345-56.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740266-500 1x 500 µL
Human IgG Immunoglobulin (IG266), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472400-500 1x 500 µL
OLIG2 (Marker of Glial Brain Tumors) (OLIG2/2400), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC401010-100 1x 100 µL
Cytochrome C (CYCS/1010), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details